Showing results (311-320 of 612) with videos related to
Sort By:
Pageof 62
Diabetic Medicine : a Journal of the British Diabetic Association|May 1, 1988
The nephrotic syndrome at presentation of insulin-dependent diabetes mellitus; cause or coincidence?T L Dornan, S Jenkins, R E Cotton, et al.Small (Weinheim an Der Bergstrasse, Germany)|January 22, 2021
Opportunities and Challenges for Integrating New In Vitro Methodologies in Hazard Testing and Risk AssessmentNatalie Burden, Martin J D Clift, Gareth J S Jenkins, et al.Diabetes, Obesity & Metabolism|April 12, 2014
Association between first-line monotherapy with sulphonylurea versus metformin and risk of all-cause mortality and cardiovascular events: a retrospective, observational studyC Ll Morgan, J Mukherjee, S Jenkins-Jones, et al.Brain Research|January 16, 1984
Vasopressin, oxytocin and neurophysins in the human brain and spinal cordJ S Jenkins, V T Ang, J Hawthorn, et al.Journal of Chronic Diseases|January 1, 1982
The effectiveness of progressive relaxation in chronic hemodialysis patientsR D Alarcon, C S Jenkins, D E Heestand, et al.British Journal of Clinical Pharmacology|March 29, 2012
Effect of angiotensin-converting enzyme inhibitor on response of plasma renin activity and aldosterone to tilting in manJ G Collier, J S Jenkins, J Keddie, et al.The British Journal of Psychiatry : the Journal of Mental Science|July 1, 1982
Estimating suicide risk among attempted suicides: I. The development of new clinical scalesD J Pallis, B M Barraclough, A B Levey, et al.Brain Research|June 15, 1981
Extrahypothalamic vasopressin in human brainM N Rossor, L L Iversen, J Hawthorn, et al.British Medical Journal|January 3, 1976
Logical approach to lignocaine therapyC Aps, J A Bell, B S Jenkins, et al.Diabetes, Obesity & Metabolism|April 26, 2014
Combination therapy with metformin plus sulphonylureas versus metformin plus DPP-4 inhibitors: association with major adverse cardiovascular events and all-cause mortalityC Ll Morgan, J Mukherjee, S Jenkins-Jones, et al.Pageof 62